Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients
- Conditions
- GaitStrokeHemiplegia
- Interventions
- Procedure: Conventional rehabilitationProcedure: Isokinetic hip flexors strengthening
- Registration Number
- NCT02917850
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
Post-stroke patients often present with gait disorders due to several physical impairments. Hip flexor deficit is one of the more prevalent trouble and is associated with gait capacities. This study aims at evaluating the impact of an isokinetic hip flexors strengthening rehabilitation program in the subacute phase after stroke. Patients will be randomized to an intervention group (isokinetic rehabilitation) or a control group (conventional rehabilitation) and assessed at the end of the rehabilitation program, at 3 and at 6 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients suffering from a first ever stroke
- At the subacute phase
- Able to walk at least 10m with or without assistive devices
- Hip flexors strength on the paretic side > 2/5 (MRC)
- Uncontrolled epilepsy
- Contraindications to physical activity (severe arterial hypertension, aortic valvulopathy, severe PAD...)
- History of muscular or joint disorders on the paretic hip
- Subject unable to deliver an informed written consent (due to aphasia, cognitive or psychiatric disorders...)
- Protected persons
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Conventional rehabilitation Patients who benefit from a conventional rehabilitation program Isokinetic Isokinetic hip flexors strengthening Patients who benefit from the hip flexors isokinetic strengthening rehabilitation program Isokinetic Conventional rehabilitation Patients who benefit from the hip flexors isokinetic strengthening rehabilitation program
- Primary Outcome Measures
Name Time Method Max gait speed (m/s) 6 weeks Gait speed will be assessed in the 10m walk test
- Secondary Outcome Measures
Name Time Method Hip flexors strength 6weeks; 3 and 6 months Hip flexors strength will be evaluated using an isokinetic dynamometer (concentric, 30°/s) and motor testing (medical research council)
Gait endurance 6 weeks; 3 and 6 months Gait endurance will be assessed using the 6MWT
Gait capacities 6 weeks; 3 and 6 months Functional ambulation categories (FAC)
Rate of perceived exhaustion during gait 6 weeks; 3 and 6 months Borg scale
Max gait speed (m/s) 3 and 6 months Gait speed will be assessed in the 10m walk test
Balance and postural control 6 weeks; 3 and 6 months Timed-up and go test